EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Effect of vitamin D supplementation on metabolic syndrome and atherosclerosis biomarkers in epilepsy: a randomized controlled trial

Sri Handayani, Zen Hafy, Fitri Octaviana, Zulkhair Ali, Nita Parisa, Astri Budikayanti, Dessy Agustini, Radiyati Umi Partan

Medicinski Glasnik · 27.02.2026 · 23 (1) · 111-116

DOI: 10.17392/2062-23-01 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Medicinski Glasnik, online erschienen am 27.02.2026. Verfasst von Sri Handayani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department, Sriwijaya University, Palembang, Indonesia. Hauptthemen laut MEDLINE: Epilepsy, Vitamin D, Metabolic Syndrome, Atherosclerosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

<p><strong>Aim </strong>To analyze the effect of vitamin D administration on serum 25(OH)D levels and biomarkers of metabolic syndrome and atherosclerosis (homeostatic model assessment of insulin resistance [HOMA-IR], adiponectin, homocysteine, and high sensitivity C-reactive protein [hs-CRP]) in epilepsy patients receiving enzymatic antiseizure medications (ASMs).</p> <p><strong>Methods </strong>This double-blind, randomized, placebo-controlled trial randomized 40 adult epilepsy patients treated with enzymatic ASMs to receive vitamin D3 (2,000 IU/day) or placebo for 12 weeks. The primary outcome was the change in serum 25-hydroxyvitamin D (25[OH]D) levels. Secondary outcomes included changes in HOMA-IR, adiponectin, homocysteine, and hs-CRP. Data were analyzed using a per-protocol approach.</p> <p><strong>Results </strong>Thirty-four patients completed the study. Vitamin D supplementation yielded a significantly greater increase in serum 25(OH)D (10.67 &plusmn; 8.16 vs. &ndash;1.29 &plusmn; 3.96 ng/mL; p &lt; 0.001) and adiponectin (1.38 &plusmn; 3.05 vs. 0.34 &plusmn; 1.89 &micro;g/mL; p = 0.045), as well as a significantly greater reduction in hs-CRP (&ndash;6.74 &plusmn; 14.65 vs. 1.81 &plusmn; 7.75 mg/L; p = 0.041) compared with placebo. Conversely, no significant differences were observed between groups regarding the changes in HOMA-IR (&ndash;0.24 &plusmn; 3.71 vs. &ndash;0.14 &plusmn; 3.38; p = 0.940) or homocysteine (7.90 &plusmn; 1.79 vs. 8.15 &plusmn; 2.70 &micro;mol/L; p = 0.290).</p> <p><strong>Conclusion </strong>Vitamin D supplementation (2,000 IU/day) effectively restores 25(OH)D levels and improves adiponectin and hs-CRP in epilepsy patients on enzymatic ASMs, suggesting a potential benefit for cardiovascular risk reduction. However, vitamin D alone did not prevent the rise in homocysteine, likely due to the concurrent cessation of B-vitamin supplementation.</p>

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyVitamin DMetabolic SyndromeAtherosclerosisCholecalciferolHumansBiomarkersFemaleMaleAdultC-Reactive ProteinDouble-Blind MethodDietary SupplementsAdiponectinHomocysteineMiddle AgedInsulin ResistanceAnticonvulsants

Stichwörter der Autor:innen

C-reactive proteinanticonvulsantscholecalciferolinsulin resistance

Substanzen

BiomarkersVitamin DC-Reactive ProteinAdiponectinHomocysteine25-hydroxyvitamin DAnticonvulsantsCholecalciferol

Autor:innen und Institutionen

  • Neurology Department, Sriwijaya University, Palembang, Indonesia.
  • Biomedicine Division, Sriwijaya University, Palembang, Indonesia.
  • Neurology Department, University of Indonesia, Depok, Indonesia.
  • Division of Nephrology and Hypertension, Department of Internal Medicine, Sriwijaya University, Palembang, Indonesia.
  • Department of Pharmacology, Sriwijaya University, Palembang, Indonesia.
  • Sriwijaya University, Palembang, Indonesia.

Zitieren

APA

Handayani, S., Hafy, Z., Octaviana, F., Ali, Z., Parisa, N., Budikayanti, A., Agustini, D., & Partan, R. U. (2026). Effect of vitamin D supplementation on metabolic syndrome and atherosclerosis biomarkers in epilepsy: a randomized controlled trial. Medicinski Glasnik, 23(1), 111-116. https://doi.org/10.17392/2062-23-01

Vancouver

Handayani S, Hafy Z, Octaviana F, Ali Z, Parisa N, Budikayanti A, et al. Effect of vitamin D supplementation on metabolic syndrome and atherosclerosis biomarkers in epilepsy: a randomized controlled trial. Medicinski Glasnik. 2026;23(1):111-116. doi:10.17392/2062-23-01

BibTeX
@article{Handayani2026,
  author = {Handayani, Sri and Hafy, Zen and Octaviana, Fitri and Ali, Zulkhair and Parisa, Nita and Budikayanti, Astri and Agustini, Dessy and Partan, Radiyati Umi},
  title = {Effect of vitamin D supplementation on metabolic syndrome and atherosclerosis biomarkers in epilepsy: a randomized controlled trial},
  journal = {Medicinski Glasnik},
  year = {2026},
  volume = {23},
  number = {1},
  pages = {111--116},
  doi = {10.17392/2062-23-01}
}
Kostenlos starten →